Recent events
Recent events tied to this brand in public sources.
Back to profile1 entries
2022
SalubrisBio secures $32 million in financing
Salubris Biotherapeutics secured $32 million in financing from Shenzhen Salubris Pharmaceuticals to advance its complex biologics for several diseases.